Categories: Technology

Family Sues OpenAI After 31-Year-Old Woman Dies Following ChatGPT Medication Advice

The family of a 31-year-old software engineer, Bowen Wan, has sued OpenAI and its chief executive, Sam Altman, alleging that ChatGPT encouraged her to reduce and eventually stop her epilepsy medication before her death.

Wan, who lived in Seattle, had battled epilepsy for years. Her condition reportedly improved after she began taking medication that reduced her seizures to a few episodes each month. However, she became concerned that the drug was affecting her thinking and speech, as well as her chances of securing another job after being laid off by Amazon in November 2025.

According to the wrongful-death lawsuit, ChatGPT initially advised Wan to consult a doctor but later allegedly helped her develop a plan to reduce her medication from 400 milligrams to zero within a few weeks.

The complaint states that Wan experienced confusion and memory problems as she reduced her dose. She reportedly raised concerns about her condition 158 times during conversations with the chatbot.

The lawsuit alleges that ChatGPT downplayed her symptoms, describing her brain as being in a “low-power mode” and telling her, “You have absolutely no need to worry.”

Wan’s epilepsy specialist, Dr Nicholas Poolos, said he would not recommend stopping medication that was effectively controlling a patient’s seizures.

“That would be malpractice for me to instruct you to go off medications when it’s clearly working,” he reportedly said.

Wan was later found dead in her Seattle apartment. Her reported cause of death was sudden unexpected death in epilepsy, commonly known as SUDEP, a condition associated with epilepsy.

Her family’s lawyers accused OpenAI of allowing ChatGPT to provide dangerous medical guidance and of treating doctors as obstacles rather than encouraging users to seek professional advice. The allegations have not been proven in court.

An OpenAI spokesperson, Drew Pusateri, described the case as an “incredibly heartbreaking situation” while stressing that ChatGPT is not a substitute for medical care.

The case raises concerns about the risks of relying on artificial intelligence for medical decisions, particularly when users are considering changes to prescribed treatment for serious conditions such as epilepsy.

 

About The Author

More From Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like